Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Epiminder Ltd

Company price
0.27 AUD -0.01 ( 3.57%)
Last update at 2026-11-12T04:59:00Z
VOLUME
72710
Market Cap
52.00M

Momentum Score

…

Epiminder Limited engages in the development and manufacture of monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. The company offers Minder system, an electroencephalographic (EEG) recording and transmitting device implanted under the scalp. Its Minder system comprises Minder Implant, a sub scalp electrode with multiple recording points which enables capture of EEG continuously for months or years; Minder Wearable, which receives and stores EEG recordings wirelessly transmitted from the Minder implant to the Minder app; Minder App that collects and transmits EEG data from the Minder implant via Bluetooth and uploads to the Minder Cloud for processing; and Minder Cloud, a secure, online portal which allows healthcare professionals to download patient data. The company was incorporated in 2017 and is based in Melbourne, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.27
Low
0.28
High
52 Week Price Range
0.24
Low
1.49
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Epiminder Ltd is an Australian Securities Exchange-listed company for which public disclosures provide limited detail about its core operations and commercial strategy. Because material growth drivers are not clearly documented, investors should monitor corporate filings, product development announcements and cash position to assess whether the company appears positioned to develop a credible pathway to revenue or asset monetization.
The principal investment risk is the lack of transparent operational and financial information combined with small-cap liquidity and financing risk that may impede execution and value realization.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.28
Dividend Yield
-
Revenue TTM
2.13M
Revenue Per Share
0.01
Gross Profit TTM
2.13M
Debt / Equity
-
ROE
-301.87%
Net Debt
-
ROCE
-52.67%
Diluted EPS TTM
-0.28

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30
Type yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30
Income before tax -42.73M -34.51M -22.39M -21.34M
Net income -42.73M -34.51M -22.39M -21.34M
Selling general administrative 16.12M 8.93M 5.99M 6.11M
Gross profit -4.00M - - -
Reconciled depreciation 0.04M 0.07M 0.09M 0.08M
Operating income -43.65M -28.59M -21.08M -20.64M
Interest expense 1.22M 3.04M 1.95M 1.01M
Tax provision 0.00M 0.00M 0.00M 0.00M
Net interest income 0.91M -3.04M -1.95M -1.01M
Cost of revenue 4.00M - - -
Total other income expense net - -2.88M 0.64M 0.31M
Net income from continuing ops -42.73M -34.51M -22.39M -21.34M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30
Type yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30
Total assets 90.84M 130.71M 0.00M 0.00M
Intangible assets 13.15M 13.15M - -
Other current assets 0.75M 0.15M - -
Total liab 9.17M 23.32M 0.00M 0.00M
Total stockholder equity 81.67M 107.39M 0.00M 0.00M
Capital stock 208.57M 207.78M - -
Retained earnings -140.99M -110.73M - -
Cash 75.79M 116.95M - 0.00M
Total current liabilities 7.97M 23.21M 0.00M 0.00M
Total current assets 77.60M 117.49M 0.00M 0.00M
Net receivables - 0.38M - -
Accounts payable 1.85M 22.64M - -
Non current assets total 13.23M 13.22M 0.00M 0.00M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30
Type yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30
Net borrowings 0.50M 14.58M 8.44M 7.56M
Total cash from financing activities 109.99M 14.58M 13.98M 10.38M
Net income -42.73M -34.51M -22.39M -21.34M
Change in cash 66.68M -2.44M 0.16M -3.90M
Begin period cash flow 8.85M 11.31M 11.17M 15.09M
End period cash flow 75.79M 8.85M 11.31M 11.17M
Issuance of capital stock 125.00M - 5.54M 2.82M
Sale purchase of stock -9.56M - - -
Capital expenditures 0.00M 0.00M 0.00M 0.00M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
EPI
Epiminder Ltd
-0.01
3.57%
0.27 - - 24.39 0.69
COH
Cochlear Ltd
2.26
1.50%
152.98 68.64 27.40 4.30 5.34
IMR
Imricor Medical Systems Inc
0.06
4.72%
1.33 - - 36401.21 17.45
AVR
Anteris Technologies Global Corp
0.50
5.88%
9.00 - - 356.02 2.19
AVH
Avita Medical Inc
-0.11
2.13%
5.06 - 9.97 9.59 7.17

Profile*

Epiminder Ltd

Epiminder Limited engages in the development and manufacture of monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. The company offers Minder system, an electroencephalographic (EEG) recording and transmitting device implanted under the scalp. Its Minder system comprises Minder Implant, a sub scalp electrode with multiple recording points which enables capture of EEG continuously for months or years; Minder Wearable, which receives and stores EEG recordings wirelessly transmitted from the Minder implant to the Minder app; Minder App that collects and transmits EEG data from the Minder implant via Bluetooth and uploads to the Minder Cloud for processing; and Minder Cloud, a secure, online portal which allows healthcare professionals to download patient data. The company was incorporated in 2017 and is based in Melbourne, Australia.

West Podium, Mezzanine 2, Melbourne, VIC, Australia, 3000

61 4 5252 1634

Name Title Year Born
Dr. Rohan J. Hoare Ph.D. CEO, MD & Director 1964
Prof. Mark Cook A.O. Founder & Chief Medical Officer NA
Mr. Mark McLellan CFO & Company Secretary NA
Dr. John Heasman Chief Operating Officer NA
Mr. Toby McSweeney CTO & VP of Quality NA
Ms. Karen Campitelli Company Secretary NA
Ms. Belinda Ann Cleminson BEd, GIA (Cert) Joint Company Secretary NA
Mr. Toby McSweeney Chief Technology Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…